Global Chemical Leasing Award 2018

In 2018, NovoPharma was honored with the Global Chemical Leasing Award, an international recognition granted to companies that implement innovative and sustainable models within the chemical industry. This achievement reflects the company’s commitment to resource optimization, process efficiency, and the development of environmentally responsible scientific solutions, positioning NovoPharma among forward-thinking organizations aligned with global sustainability standards.

American Dermatologist Development Institute Recognition

NovoPharma received recognition from the American Dermatologist Development Institute for its contribution to advancing dermatological solutions and its focus on developing products that improve skin and hair health. This acknowledgment highlights the company’s ability to integrate applied science with real-world impact on user well-being.

European Commission – Sciences and Technology Area

NovoPharma’s alignment with the European Commission’s Sciences and Technology standards demonstrates its commitment to scientific excellence, technological innovation, and compliance with international regulatory frameworks. This recognition reinforces the company’s position within a global ecosystem driven by research and quality.

Global Chemical Leasing Award 2018 – Research & Special Innovation

As part of the same international framework, NovoPharma was also recognized in the Research & Special Innovation category, highlighting its ability to develop differentiated scientific solutions. This distinction reinforces the company’s strong focus on applied research and innovation with tangible market impact.

Startup Europe Awards 2018 – Science Category

In 2018, NovoPharma was recognized at the Startup Europe Awards in the Science category, highlighting its potential as an emerging leader in the scientific sector. This award positioned the company as a high-growth organization with strong international projection in biotechnology and applied genetic solutions.

Affordable Care Act (ACA) Alignment – U.S. Health Standards

NovoPharma demonstrates alignment with principles established under the Affordable Care Act (ACA) in the United States, reflecting its commitment to accessible health and wellness solutions. This alignment supports the company’s mission to deliver high-quality, responsible, and scalable healthcare-oriented innovations.